Lian Meifei, Zhao Kai, Feng Yunzhi, Yao Qian
Int J Oral Maxillofac Implants. 2018 March/April;33(2):281–297. doi: 10.11607/jomi.5796. Epub 2017 Sep 22.
The reliability of combining natural teeth and implants in one removable prosthesis is controversial. This systematic review was conducted to evaluate the prognosis of combined tooth/implant-supported double-crown-retained removable dental prostheses (DCR-RDPs) and to compare them with solely implant-supported prostheses with a minimum observation period of 3 years.
Electronic database (PubMed, Embase, Central, and SCI) and manual searches up to August 2016 were conducted to identify human clinical studies on tooth/implant-supported DCR-RDPs. Literature selection and data extraction were accomplished by two independent reviewers. Meta-analyses of survival and complication rates were performed separately for combined tooth/implant-supported and solely implant-supported DCRRDPs.
Among the initially identified 366 articles, 17 were included in a quantitative analysis. The estimated overall cumulative survival rate (CSR) for implants in combined tooth/implant-supported DCRRDPs was 98.72% (95% confidence interval [95% CI]: 96.98% to 99.82%), and that for implants in solely implant-supported DCR-RDPs was 98.83% (95% CI: 97.45% to 99.75%). The summary CSR for abutment teeth was 92.96% (95% CI: 85.38% to 98.12%). Double-crown-retained dentures with both abutment types showed high CSRs, most of which were approximately 100%. Regarding prosthetic maintenance treatment, the estimated incidence for patients treated with combined tooth/implant-supported RDPs was 0.164 (95% CI: 0.089 to 0.305) per patient per year (T/P/Y) and that for patients restored with solely implant-supported RDPs was 0.260 (95% CI: 0.149 to 0.454) T/P/Y. Based on four studies with combined tooth/implant-supported DCR-RDPs, no intrusion phenomena were encountered.
Subject to the limitations of the present review, combining remaining teeth and implants in DCR-RDPs is a reliable and predictable treatment modality for partially edentulous patients. Comparable high survival rates and minor biologic or technical complications are observed for combined tooth/implant-supported and solely implant-supported DCR-RDPs. Due to the heterogeneity of the included studies, the results must be interpreted with caution.
在一个可摘义齿中联合天然牙和种植体的可靠性存在争议。本系统评价旨在评估联合牙/种植体支持的双冠固位可摘局部义齿(DCR-RDPs)的预后,并将其与观察期至少为3年的单纯种植体支持的义齿进行比较。
进行电子数据库(PubMed、Embase、Central和SCI)检索以及截至2016年8月的手工检索,以识别关于牙/种植体支持的DCR-RDPs的人体临床研究。文献筛选和数据提取由两名独立的审阅者完成。分别对联合牙/种植体支持和单纯种植体支持的DCR-RDPs的生存率和并发症发生率进行Meta分析。
在最初识别的366篇文章中,17篇被纳入定量分析。联合牙/种植体支持的DCR-RDPs中种植体的估计总体累积生存率(CSR)为98.72%(95%置信区间[95%CI]:96.98%至99.82%),单纯种植体支持的DCR-RDPs中种植体的估计总体累积生存率为98.83%(95%CI:97.45%至99.75%)。基牙的汇总CSR为92.96%(95%CI:85.38%至98.12%)。两种基牙类型的双冠固位义齿均显示出较高的CSR,其中大多数约为100%。关于修复体维护治疗,联合牙/种植体支持的RDPs治疗患者的估计发生率为每年每位患者0.164(95%CI:0.089至0.305)(T/P/Y),单纯种植体支持的RDPs修复患者的估计发生率为每年每位患者0.260(95%CI:0.149至0.454)(T/P/Y)。基于四项联合牙/种植体支持的DCR-RDPs研究,未遇到下沉现象。
受本评价的局限性影响,在DCR-RDPs中联合余留牙和种植体对于部分牙列缺损患者是一种可靠且可预测的治疗方式。联合牙/种植体支持和单纯种植体支持的DCR-RDPs观察到相当高的生存率以及轻微的生物学或技术并发症。由于纳入研究的异质性,结果必须谨慎解释。